Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats

Clinical and Experimental Nephrology

Volumn 8, Issue 3, 2004, Pages 206-215

  Kuroda, Tadahide ^a,b   Yoshida, Yutaka ^a   Kamiie, Junichi ^a   Kovalenko, Pavel ^a   Nameta, Masaaki ^a   Fujinaka, Hidehiko ^a   Yaoita, Eishin ^a   Endo, Tetsuya ^b   Ishizuka, Shunji ^b   Nakabayashi, Kimimasa ^b   Yamada, Akira ^b   Nagasawa, Toshihiko ^b   Yamamoto, Tadashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti GBM glomerulonephritis; Mesangial cell; MMP 2; MMP 9; TIMP 1

Indexed keywords

COLLAGEN TYPE 4; GELATIN; GELATINASE A; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; HISTOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT STRAIN; RIBONUCLEASE PROTECTION ASSAY; ZYMOGRAPHY;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GELATIN; GLOMERULAR MESANGIUM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, FLUORESCENCE; NUCLEASE PROTECTION ASSAYS; RATS; RATS, INBRED WKY; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 7044247785     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0289-8     Document Type: Article

References (32)

1. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000;14:2123-33.
2. Nagase H, Okada Y. Proteinases and matrix degradation. In: Kelley WN, Ruddy S, Harris EH, Sledge CB, editors. Textbook of rheumatology. 5th Ed. Philadelphia: WB Saunders; 1997. p. 323-42
3. Marti HP. The role of matrix metalloproteinases in activation of mesangial cells. Transplant Immunol 2002;9:97-100.
4. Lelongt B, Legallicier B, Piedagnel R, Ronco PM. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? Curr Opin Nephrol Hypertens 2001;10:7-12.
5. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000;11:574-81.
6. Lelongt B, Bengatta S, Delauche M, et al. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J Exp Med 2001;193:793-802.
7. Frisch SM, Morisaki JH. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol Cell Biol 1990;10:6524-32.
8. Mertens PR, Harendza S, Pollock AS, Lovett DH. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem 1997;272:2205-12.
9. Hibbs MS, Bainton DF. Human neutrophil gelatinase is a component of specific granules. J Clin Invest 1989;84:1395-402.
10. Robinson SC, Scott KA, Balkwill FR. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α. Eur J Immunol 2002;32:404-12.
11. Watanabe K, Kinoshita S, Nakagawa H. Gelatinase secretion by glomerular epithelial cells. Nephron 1990;56:405-9.
12. Martin J, Knowlden J, Davies M, Williams JD. Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int 1994;46:877-85.
13. Harendza S, Schneider A, Helmchen U, Stahl RAK. Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat. Nephrol Dial Transplant 1999;14:2873-9.
14. Steinmann-Niggli K, Ziswiler R, Küng M, Marti HP. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis. J Am Soc Nephrol 1998;9:397-407.
15. Steinmann-Niggli K, Lukes M, Marti HP. Rat mesangial cells and matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation. J Am Soc Nephrol 1997;8:395-405.
16. Marti HP. New strategy to treat glomerular inflammation by inhibition of mesangial cell matrix metalloproteinases. Schweiz Med Wochenschr 2000;130:784-8.
17. Lenz O, Striker LJ, Jacot TA, et al. Glomerular endothelial cells synthesize collagens but little gelatinase A and B. J Am Soc Nephrol 1998;9:2040-7.
18. McMillan JI, Riordan JW, Couser WG, et al. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996;97:1094-101.
19. Shiozawa S. Participation of macrophages in glomerular sclerosis through the expression and activation of matrix metalloproteinases. Pathol Int 2000;50:441-57.
20. Martin J, Steadman R, Knowlden J, et al. Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro. J Am Soc Nephrol 1998;9:1629-37.
21. Eberhardt W, Beeg T, Beck KF, et al. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 2000;57:59-69.
22. Kawasaki K, Yaoita E, Yamamoto T, Kihara I. Depletion of CDS positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 1992;41:1517-26.
23. Kamiie J, Nameta M, Ma M, et al. Localization and expression of the aquaporin-1 water channel in mesangial cells in the human glomerulus. Arch Histol Cytol 2002;65:83-90.
24. Bensadoun A, Weinstein D. Assay of proteins in the presence of interfering materials. Anal Biochem 1976;70:241-50.
25. Nihei K, Koyama Y, Tani T, et al. Immunolocalization of aquaporin-9 in rat hepatocytes and leydig cells. Arch Histol Cytol 2001;64:81-8.
26. Yamamoto T, Yamamoto K, Kawasaki K, et al. Immunoelectron microscopic demonstration of Thy-1 antigen on the surfaces of mesangial cells in the rat glomerulus. Nephron 1986;43:293-8.
27. Sambrook J, Fritsch FF, Maniatis T. Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In: Molecular cloning, a laboratory manual. 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989: chapter 7. p. 71-8.
28. Yamamoto T, Feng L, Mizuno T, et al. Expression of mRNA for natriuretic peptide receptor subtypes in bovine kidney. Am J Physiol 1994;267:F318-24.
29. Koshikawa N, Yasumitsu H, Umeda M, Miyazaki K. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 1992;52:5046-53.
30. Johnson R, Yamabe H, Chen YP, et al. Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase. J Am Soc Nephrol 1992;2:1388-97.
31. Sraer JD, Adida C, Peraldi MN, et al. Species-specific properties of the glomerular mesangium. J Am Soc Nephrol 1993;3:1342-50.
32. Cook HT, Khan SB, Allen A, et al. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis. Am J Pathol 2002;161:1265-72.